IRIDEX CORPORATION - COMMON STOCK

Iridex Comments on Changing Glaucoma Reimbursement Landscape

19 ноя 2024 08:14:07 Источник Nasdaq GlobeNewswire

Iridex Reports Third Quarter 2024 Financial Results

12 ноя 2024 16:05:01 Источник Nasdaq GlobeNewswire

Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

04 ноя 2024 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Appoints Patrick Mercer as Chief Executive Officer

03 окт 2024 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Reports Second Quarter 2024 Financial Results

08 авг 2024 16:05:01 Источник Nasdaq GlobeNewswire

Iridex Announces Convertible Note Financing

05 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire

Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024

30 июл 2024 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Reports First Quarter 2024 Financial Results

14 май 2024 16:05:00 Источник Nasdaq GlobeNewswire

Iridex to Report First Quarter 2024 Financial Results on May 14, 2024

08 май 2024 16:05:01 Источник Nasdaq GlobeNewswire

Iridex Reports Fourth Quarter and Full Year 2023 Financial Results

26 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024

20 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire

Iridex Corporation Receives European Patent on MicroPulse Technology

06 фев 2024 08:00:00 Источник Nasdaq GlobeNewswire

Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust

24 янв 2024 08:00:00 Источник Nasdaq GlobeNewswire

Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma

11 янв 2024 18:45:36 Источник Nasdaq GlobeNewswire

Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation

28 дек 2023 18:00:56 Источник Nasdaq GlobeNewswire

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

27 ноя 2023 09:00:00 Источник Nasdaq GlobeNewswire

Iridex Reports Third Quarter 2023 Financial Results and Business Update

14 ноя 2023 16:21:39 Источник Nasdaq GlobeNewswire

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

13 ноя 2023 09:00:00 Источник Nasdaq GlobeNewswire

Iridex to Report Third Quarter Financial Results on November 14, 2023

26 окт 2023 16:22:40 Источник Nasdaq GlobeNewswire

Iridex Announces Strategic Review to Unlock Shareholder Value

29 авг 2023 16:05:00 Источник Nasdaq GlobeNewswire